Quarterly report · Q2
6029.TEDINET S100RNVJ
Period2023-01-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥4.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥65m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥13m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥58m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥15m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥21m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥56m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥10m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥72m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥26m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥72m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥26m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥4.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥4.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.9bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥10m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥133m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥175m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥37m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥154m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥65m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥178m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥315m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥335m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-7.31 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.24 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.22 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.63 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.73 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 30.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.4% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥6m |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥55m |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥27m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥782m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥782m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥32m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥2.2bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥2.1bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥55m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E30998-000Acupuncture Moxibustion And Judo Therapy Clinic Support Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥67m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥832m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥832m |
| jpcrp040300-q2r_E30998-000Toy Sales Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥52m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥2.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥2.2bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥14m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 475
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 200000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 19900000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -228570000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -195249000 | JPY |
| Payments for issuance of subscription rights to shares fin cf | Prior1YTDDuration | -4583000 | JPY |
| Payments for issuance of subscription rights to shares fin cf | CurrentYTDDuration | - | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -216000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -112000 | JPY |
| Other net fin cf | Prior1YTDDuration | -1718000 | JPY |
| Other net fin cf | CurrentYTDDuration | -2299000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -335088000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -177761000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -575517000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -224237000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1835494000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1234142000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1259976000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1009905000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 262777000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 227871000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -1242000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -2764000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 6753000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 6417000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 9457000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 4762000 | JPY |
| Provision for point card certificates sga | Prior1YTDDuration | 2721000 | JPY |
| Provision for point card certificates sga | CurrentYTDDuration | 2281000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 1337257000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E30998-000ToySalesBusinessReportableSegmentMember | 831884000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 2169141000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 2169141000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E30998-000ToySalesBusinessReportableSegmentMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 1337257000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E30998-000ToySalesBusinessReportableSegmentMember | 831884000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 2169141000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration | 2169141000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | -66672000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E30998-000ToySalesBusinessReportableSegmentMember | 52182000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -14490000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 1200000 | JPY |
| Operating income | Prior1YTDDuration | -13290000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E30998-000AcupunctureMoxibustionAndJudoTherapyClinicSupportBusinessReportableSegmentMember | 1326539000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E30998-000ToySalesBusinessReportableSegmentMember | 781639000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |